The Technical Analyst
iPath Goldman Sachs [BWV]
Exchange: NYSE Sector: Healthcare Industry: Biotechnology
iPath Goldman Sachs Price, Forecast, Insider, Ratings, Fundamentals & Signals
-6.97% $0.180
America/New_York / 21 des 2023 @ 15:59
iPath Goldman Sachs PE Comparison
Report updated: 2024-05-20 @ 03:13| Comp | Ticker | PE |
|---|---|---|
| Kadmon Holdings Inc | KDMN | -13.324 |
| Myovant Sciences Ltd | MYOV | -12.100 |
| Panacea Acquisition Corp. | NUVB | -5.400 |
| Dynegy Inc. | DYN | -4.750 |
| Zymeworks Inc | ZYME | -1.950 |
| ADC Therapeutics SA | ADCT | -1.860 |
| Biohaven Pharmaceutical | BHVN | -1.500 |
| Ginkgo Bioworks Holdings, | DNA | -1.000 |
| Anthem Inc. Corporate | ANTX | -1.000 |
| iPath Goldman Sachs | BWV | -0.880 |
| SQZ Biotechnologies | SQZ | -0.270 |
| Gelesis Holdings, Inc. | GLS | -0.030 |
| Ambrx Biopharma Inc. | AMAM | 0.310 |
| Arcus Biosciences Inc | RCUS | 18.820 |
| Novo Nordisk A/S | NVO | 41.990 |